GlassScriptPhysician profile
Kristopher Joel Hansen
NPI 1326485202
$605.63
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $606.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $80.02 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $55.65 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.73 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $42.06 | 2019 | |
| Novartis Pharmaceuticals Corporation | $39.55 | 2019 | |
| Janssen Biotech, INC. | $35.38 | 2019 | |
| Merck Sharp & Dohme LLC | $35.20 | 2019 | |
| Kyowa Kirin, INC. | $35.03 | 2019 | |
| Pfizer INC. | $31.64 | 2019 | |
| Genentech USA, INC. | $27.01 | 2019 | |
| Amgen INC. | $26.69 | 2019 | |
| Celgene Corporation | $21.34 | 2019 | |
| Foundation Medicine, INC. | $19.70 | 2019 | |
| Eisai INC. | $19.49 | 2019 | |
| Alexion Pharmaceuticals, INC. | $16.63 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $15.95 | 2019 | |
| Puma Biotechnology, INC. | $12.99 | 2019 | |
| Agios Pharmaceuticals, INC. | $11.78 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.73 | 2019 | |
| Dova Pharmaceuticals | $11.71 | 2019 | |
| Astellas Pharma US INC | $11.35 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristopher Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.